An inhibitor of in vivo proteolysis, which comprises, as an active principle, a fatty acid-based compound containing one acyl group (RCO-) having 6 to 12 carbon atoms, preferably a fatty acid precursor which is converted into a fatty acid having 6 to 12 carbon atoms in vivo.